Pharma exec convicted of wire fraud for off-label promotion; Eli Lilly settles Connecticut Zyprexa suit;

> An executive with pharmaceutical firm InterMune has been convicted of wire fraud for sending out a misleading press release that boosted off-label sales of a company drug. FiercePharma

> Drugmaker Eli Lilly has settled another state lawsuit, this time in Connecticut, alleging that it marketed antipsychotic drug Zyprexa for unapproved uses such as dementia and attention-deficit disorder. FiercePharma

> Hospital costs for serious infections have tripled from 1997 to 2007, with skin and subcutaneous tissue infections rising 90 percent for men and 75 percent for women during that period. FierceHealthFinance

> Read to recruit physicians? Make sure you're up to date on the latest physician pay models, which have come to vary considerably, note a pair of consultants in a recent column. FierceHealthFinance

And Finally... This has got to be the cutest H1N1 microbe ever. (Even your kids will like it!) Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.